Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Endocrinology)
Gastroenterologist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
MD(Neurology), F.C.P.S. (Medicine), MRCP (UK), FRCP LONDON
Internal Medicine Specialist
MD(Neurology), F.C.P.S. (Medicine), MRCP (UK), FRCP LONDON
Diabetologist
MD
Internal Medicine Specialist
M.B.B.S., F.C.P.S Medicine , MRCP UK, Fellowship Training in Endocrinology
Internal Medicine Specialist
M.B.B.S., F.C.P.S Medicine , MRCP UK, Fellowship Training in Endocrinology
General Physician
MBBS, MCPS (Family Medicine)
Family Physician
M.B.B.S, D.D.M
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Pulmonologist
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S. (Pulmanology)
Pulmonologist
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S. (Pulomonogy)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures